Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 6 de 6
Filtrar
Más filtros












Intervalo de año de publicación
1.
Eur J Neurol ; 20(2): 271-80, 2013 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-22967035

RESUMEN

BACKGROUND AND PURPOSE: Safinamide is an α-aminoamide with both dopaminergic and non-dopaminergic mechanisms of action in Phase III clinical development as a once-daily add-on to dopamine agonist (DA) therapy for early Parkinson's disease (PD). METHODS: Study 017 was a 12-month, randomized, double-blind, placebo-controlled pre-planned extension study to the previously reported Study 015. Patients received safinamide 100 or 200 mg/day or placebo added to a single DA in early PD. The primary efficacy endpoint was the time from baseline (Study 015 randomization) to 'intervention', defined as increase in DA dose; addition of another DA, levodopa or other PD treatment; or discontinuation due to lack of efficacy. Safinamide groups were pooled for the primary efficacy endpoint analysis; post hoc analyses were performed on each separate dose group. RESULTS: Of the 269 patients randomized in Study 015, 227 (84%) enrolled in Study 017 and 187/227 (82%) patients completed the extension study. Median time to intervention was 559 and 466 days in the pooled safinamide and placebo groups, respectively (log-rank test; P = 0.3342). In post hoc analyses, patients receiving safinamide 100 mg/day experienced a significantly lower rate of intervention compared with placebo (25% vs. 51%, respectively) and a delay in median time to intervention of 9 days (P < 0.05; 240- to 540-day analysis). CONCLUSIONS: The pooled data from the safinamide groups failed to reach statistical significance for the primary endpoint of median time from baseline to additional drug intervention. Post hoc analyses indicate that safinamide 100 mg/day may be effective as add-on treatment to DA in PD.


Asunto(s)
Alanina/análogos & derivados , Antiparkinsonianos/uso terapéutico , Bencilaminas/uso terapéutico , Agonistas de Dopamina/uso terapéutico , Enfermedad de Parkinson/tratamiento farmacológico , Adulto , Anciano , Anciano de 80 o más Años , Alanina/administración & dosificación , Alanina/efectos adversos , Alanina/farmacocinética , Alanina/uso terapéutico , Antiparkinsonianos/administración & dosificación , Antiparkinsonianos/farmacocinética , Bencilaminas/administración & dosificación , Bencilaminas/efectos adversos , Bencilaminas/farmacocinética , Agonistas de Dopamina/administración & dosificación , Agonistas de Dopamina/farmacocinética , Método Doble Ciego , Quimioterapia Combinada , Intervención Médica Temprana/métodos , Femenino , Humanos , Masculino , Persona de Mediana Edad , Índice de Severidad de la Enfermedad
2.
Acta neurol. colomb ; 25(3): 101-113, sept. 2009.
Artículo en Español | LILACS | ID: lil-537985
3.
Bull World Health Organ ; 78(3): 399-406, 2000.
Artículo en Inglés | MEDLINE | ID: mdl-10812740

RESUMEN

Neurocysticercosis is an infection of the nervous system caused by Taenia solium. It is the most important human parasitic neurological disease and a common cause of epilepsy in Africa, Asia, and Latin America, representing enormous costs for anticonvulsants, medical resources and lost production. Neurocysticercosis is a human-to-human infection, acquired by the faecal-enteric route from carriers of intestinal T. solium, most often in areas with deficient sanitation. Intestinal tapeworms cause few symptoms, but adult taeniae carried by humans release large numbers of infective eggs and are extremely contagious. Ingestion of poorly cooked pig meat infested with T. solium larvae results in intestinal taeniosis but not neurocysticercosis. With a view to hastening the control of taeniosis and neurocysticercosis we propose that neurocysticercosis be declared an international reportable disease. New cases of neurocysticercosis should be reported by physicians or hospital administrators to their health ministries. An epidemiological intervention could then be launched to interrupt the chain of transmission by: (1) searching for, treating and reporting the sources of contagion, i.e. human carriers of tapeworms; (2) identifying and treating other exposed contacts; (3) providing health education on parasite transmission and improvement of hygiene and sanitary conditions; and (4) enforcing meat inspection policies and limiting the animal reservoir by treatment of pigs. We believe that the first step required to solve the problem of neurocysticercosis is to implement appropriate surveillance mechanisms under the responsibility of ministries of health. Compulsory notification also has the major advantage of providing accurate quantification of the incidence and prevalence of neurocysticercosis at regional level, thus permitting the rational use of resources in eradication campaigns.


Asunto(s)
Cooperación Internacional , Neurocisticercosis/epidemiología , Adolescente , Adulto , Niño , Países Desarrollados , Países en Desarrollo , Notificación de Enfermedades , Humanos , Incidencia , Persona de Mediana Edad , Neurocisticercosis/etiología , Vigilancia de la Población
4.
J Nutr ; 129(3): 687-92, 1999 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-10082775

RESUMEN

This study was designed to develop an abbreviated method that captures both the qualitative and quantitative dimensions of household food security (HFS). Women in poor and very poor households (n = 238) in a peri-urban barrio in Caracas, Venezuela, provided data on food availability and their perception of food resource constraints and hunger experiences within the home. Socioeconomic data and food-related behavior that may predict HFS levels were gathered. On average, the top 12 food contributors of energy provided 81% and predicted more than 90% of the variation in households' total energy availability using stepwise regression analysis. On the other hand, a 4-point 12-item scale was shown to have face, content and construct validity with reiterative testing, factor analysis and a Chronbach's alpha coefficient of 0.92. Assessing predictors of energy availability together with a self-perceived HFS scale may provide a valid and reliable method for identifying and monitoring food security levels among poor urban households.


Asunto(s)
Abastecimiento de Alimentos , Pobreza , Ingestión de Energía , Familia , Femenino , Alimentos/economía , Humanos , Hambre , Percepción , Proyectos Piloto , Análisis de Regresión , Factores Socioeconómicos , Encuestas y Cuestionarios , Población Urbana , Venezuela
5.
J Clin Exp Neuropsychol ; 9(4): 399-406, 1987 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-3597731

RESUMEN

A case of advanced Wilson's disease with clear dementing features is presented. Neuropsychological evaluation before treatment revealed intellectual deterioration particularly in memory and performance tasks. The patient was treated with Penicillamine, a copper-chelating agent, for 7 months, with notable improvement in her dementia and in her motor signs. A second battery of neuropsychological tests demonstrated the improvement in the mental aspects. These findings support the concept of Wilson's disease being a reversible dementia.


Asunto(s)
Demencia/diagnóstico , Degeneración Hepatolenticular/diagnóstico , Adulto , Demencia/tratamiento farmacológico , Demencia/psicología , Femenino , Degeneración Hepatolenticular/tratamiento farmacológico , Degeneración Hepatolenticular/psicología , Humanos , Pruebas Neuropsicológicas , Penicilamina/uso terapéutico , Tomografía Computarizada por Rayos X
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...